VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNTEZHNFNiQUJqVFpKbzgzNjlaNjNzSGRUdXh3QnlObmJqWXBWZ29IVkJmVmg5MUpoT1B6cERvWmZYUWU1TlIxSVkwblFiOGxYZjYtR0doZ0NZZ29JTHFIMUNDQVFzd29RSTRxQ0NuOWhsa3NtSTMwWk14dlhlLTVMakJqR2ZxUXN4YlRwMXhnTkg2dzB4eTN0NnFIMmY3MEVJOWNsVGxPMERja0cwTURmOVVxMlppbHNMSXBVUEFOUVRFZFVxZUs0?oc=5" target="_blank">VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
UniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
September 29, 2026 at 10:11 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMNovartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMModerna to replace Warner Bros Discovery on Nasdaq 100 - Reuters
Moderna to replace Warner Bros Discovery on Nasdaq 100 Reuters
October 2, 2026 at 12:12 AM